Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors
    71.
    发明授权
    Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors 失效
    分类,诊断,分层和治疗癌症患者及其肿瘤的方法

    公开(公告)号:US07118853B2

    公开(公告)日:2006-10-10

    申请号:US09916849

    申请日:2001-07-26

    CPC classification number: C07K14/4748 A61K38/00 C07K16/18

    Abstract: The invention provides a variety of reagents for use in the diagnosis and management of breast cancer. The invention utilizes cDNA microarray technology to identify genes whose expression profile across a large group of tumor samples correlates with that of cytokeratin 5 and cytokeratin 17, markers for basal cells of the normal mammary lactation gland. The invention demonstrates that tumors that express cytokeratin 5/6 and/or 17 have a poor prognosis relative to tumors overall. The invention provides basal marker genes and their expression products and uses of these genes for diagnosis of breast cancer and for identification of therapies for breast cancer. In particular, the invention provides basal marker genes including cadherin3, matrix metalloproteinase 14, and cadherin EGF LAG seven-pass G-type receptor 2. The invention provides antibodies to the polypeptides expressed by these genes and methods of use thereof.

    Abstract translation: 本发明提供用于诊断和治疗乳腺癌的各种试剂。 本发明利用cDNA微阵列技术鉴定了大量肿瘤样本的表达谱与细胞角蛋白5和细胞角蛋白17(正常乳腺泌乳腺基底细胞的标记)相关的基因。 本发明表明,表达细胞角蛋白5/6和/或17的肿瘤总体上相对于肿瘤的预后差。 本发明提供了基础标记基因及其表达产物和这些基因用于乳腺癌诊断和鉴定乳腺癌疗法的用途。 特别地,本发明提供了包括钙粘蛋白3,基质金属蛋白酶14和钙粘蛋白EGF LAG七通G型受体2的基础标记基因。本发明提供了由这些基因表达的多肽的抗体及其使用方法。

Patent Agency Ranking